News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
166 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (27010)
Month
January (2722)
February (2862)
March (3369)
April (3287)
May (3419)
June (3649)
July (3258)
August (3461)
September (3585)
October (3789)
November (3817)
December (2398)
Day
1 (144)
4 (208)
5 (201)
6 (192)
7 (165)
8 (156)
11 (174)
12 (194)
13 (155)
14 (168)
15 (158)
16 (1)
18 (166)
19 (192)
20 (191)
21 (201)
22 (164)
25 (170)
26 (218)
27 (178)
28 (215)
29 (178)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
4
5
6
7
8
11
12
13
14
15
16
18
19
20
21
22
25
26
27
28
29
Pharm Country
Penwest Pharmaceutical Announces Intention to Terminate NASDAQ Listing and Registration
October 18, 2010
·
1 min read
Drug Development
Neurocrine Biosciences, Inc. Announces That VMAT2 Program Will Move Into Phase II Clinical Trials
October 18, 2010
·
3 min read
Drug Development
Phase 2b Data Suggest ReVision Therapeutics, Inc.'s Oral Fenretinide (RT-101) Slows Lesion Growth, Preserves Vision and Reduces Incidence of Neovascularization in Geographic Atrophy Patients
October 18, 2010
·
4 min read
Drug Development
Long-Term Data Show Novartis Corporation Once-Yearly Reclast Preserves Bone Mass and Provides Fracture Protection in Postmenopausal Osteoporosis
October 18, 2010
·
9 min read
Business
CryoLife, Inc. Announces Release Date and Teleconference Call Details for 2010 Third Quarter Financial Results
October 18, 2010
·
2 min read
BioForest
Infectious Disease Research Institute (IDRI) Develops Novel Tuberculosis Vaccine, New Study in Science Reports
October 18, 2010
·
1 min read
Bio NC
Argos Therapeutics, Inc. to Present Overview of its Arcelis(TM) Dendritic Cell-based Immunotherapy, Participate in Panel Discussion at Inaugural Cancer Immunotherapy Conference
October 18, 2010
·
1 min read
Genetown
Generex Biotechnology Corporation Provides Additional Reverse Stock Split Information for the Consideration of Stockholders
October 18, 2010
·
5 min read
Business
Goodwin Biotechnology, Inc. Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
October 18, 2010
·
2 min read
Drug Development
S*Bio’s JAK2 Inhibitor SB1518 Granted Orphan Drug Designation by European Commission for the Treatment of Myelofibrosis
October 18, 2010
·
3 min read
Previous
6 of 17
Next
